mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |